Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ImmunityBio
ImmunityBio is a clinical-stage immunotherapy biotech based in California.
Biotech
ImmunityBio touts 15-month complete response in CAR-NK trial
ImmunityBio reported ongoing complete responses of up to 15 months in two recipients of its off-the-shelf CAR-NK cell therapy.
Nick Paul Taylor
Jan 16, 2026 9:19am
CG sets new bar in bladder cancer, months after huge IPO
May 3, 2024 11:23am
ImmunityBio inks $210M royalty deal to get cancer drug to market
Jan 2, 2024 7:41am
Second layoff wave hits ImmunityBio in less than a year
Sep 22, 2023 11:22am
